Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the ...

Merck & Co., Inc. (NYSE:MRK) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Merck & Co., Inc.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 2024. That’s a compound annual growth rate ...

Merck & Co., Inc. has been catching eyes with its recent stock price movements. Despite a slight dip last week, the overall ...

Shares of Merck MRK have rallied almost 14% so far this week as investors’ optimism grew concerning the broader pharmaceutical sector in the United States after Pfizer PFE announced a landmark deal ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Merck's strong drug pipeline, oncology leadership, and 3.8% dividend yield make it a top long-term investment pick. Learn ...

Turning $10,000 into $50,000 in about five years would require a compound annual growth rate (CAGR) of almost 38%. That's an ...

Merck & Co., Inc. finds itself at a pivotal point as recent events stir the pot in the pharmaceutical landscape. With the ...